Medacta Group SA - Asset Resilience Ratio
Medacta Group SA (MOVE) has an Asset Resilience Ratio of 0.86% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Medacta Group SA to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Medacta Group SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Medacta Group SA (MOVE) total assets.
Liquid Assets Composition Over Time
This chart breaks down Medacta Group SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore MOVE strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 0% |
| Short-term Investments | CHF7.45 Million | 0.86% |
| Total Liquid Assets | CHF7.45 Million | 0.86% |
Asset Resilience Insights
- Limited Liquidity: Medacta Group SA maintains only 0.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medacta Group SA Industry Peers by Asset Resilience Ratio
Compare Medacta Group SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Medacta Group SA (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Medacta Group SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.59% | CHF4.69 Million ≈ $5.93 Million |
CHF792.18 Million ≈ $1.00 Billion |
-0.42pp |
| 2023-12-31 | 1.01% | CHF7.05 Million ≈ $8.91 Million |
CHF695.87 Million ≈ $879.77 Million |
+0.88pp |
| 2022-12-31 | 0.14% | CHF802.00K ≈ $1.01 Million |
CHF584.49 Million ≈ $738.95 Million |
-- |
| 2021-12-31 | 0.00% | CHF0.00 ≈ $0.00 |
CHF489.27 Million ≈ $618.56 Million |
-- |
| 2020-12-31 | 0.29% | CHF1.30 Million ≈ $1.64 Million |
CHF441.94 Million ≈ $558.73 Million |
+0.23pp |
| 2019-12-31 | 0.06% | CHF259.00K ≈ $327.45K |
CHF412.56 Million ≈ $521.59 Million |
0.00pp |
| 2018-12-31 | 0.07% | CHF240.00K ≈ $303.42K |
CHF365.60 Million ≈ $462.21 Million |
-- |
| 2017-12-31 | 0.00% | CHF0.00 ≈ $0.00 |
CHF299.81 Million ≈ $379.04 Million |
-- |
| 2016-12-31 | 0.19% | CHF500.00K ≈ $632.14K |
CHF269.68 Million ≈ $340.95 Million |
-- |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.